|

UCB-NK cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Radboud University Medical Center1

Indications

  • Acute Myeloid Leukemia Refractory1
  • Acute Myeloid Leukemia, Relapsed, Adult1
  • Cancer1

Other1 trial

Natural Killer-cell Therapy for Acute Myeloid Leukemia
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.